Global Mammography Biopsy Chair Market, by Product Type (Electric, Manual), by Feature (Reclining, Non-Reclining), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others (Cancer Research Institutes, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 120.0 Mn in 2022 and is expected to exhibit a CAGR of 4.3% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing rate of mammogram screening is expected to increase usage of mammography biopsy chairs which is anticipated to augment the global mammography biopsy chair market growth during the forecast period.
For instance, according to the data provided by the Breastcancer.org, a nonprofit organization, in the year 2019, around 6,500 diagnostic mammograms and 28,000 screening mammograms were done per month in the U.S.
Moreover, in April 2020, about 317 screening mammograms and 1,452 diagnostic mammograms were performed in the U.S.
Global Mammography Biopsy Chair Market – Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019 in Wuhan, China. The World Health Organization declared COVID-19 a pandemic on March 11, 2020.
According to the coronavirus disease (COVID-19) weekly epidemiological update by the World Health Organization, over 596,873,121 cases and 6,459,684 deaths due to coronavirus disease (COVID-19) were reported across the globe as of August 26th, 2022
The COVID-19 pandemic has significantly affected several markets across the globe and is also expected to make impact on the global mammography biopsy chair market.
In July 2020, the U.S. Food and Drug Administration (FDA) announced that domestic inspections were anticipated to resume with prioritization on the basis of risk and other factors. Many Mammography Quality Standards Act (MQSA) inspections have resumed under this plan.
Browse 40 Market Data Tables and 48 Figures spread through 197 Pages and in-depth TOC on “Global Mammography Biopsy Chair Market”- Global Forecast to 2030, Global Mammography Biopsy Chair Market, by Product Type (Electric, Manual), by Feature (Reclining, Non-Reclining), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others (Cancer Research Institutes, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa).
To know the latest trends and insights prevalent in the Global Mammography Biopsy Chair Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/mammography-biopsy-chair-market-5225
Moreover, increasing number of biopsy procedures is expected to drive growth of the global mammography biopsy chair market over the forecast period.
For instance, according to the data published by the Elsevier, a publishing company in the year 2020, breast biopsy provides the only definitive diagnosis for breast cancer. There are over 3 million breast biopsies performed in the U.S. per year.
Key Takeaways of the Global Mammography Biopsy Chair Market:
- Global mammography biopsy chair market is expected to exhibit a CAGR of 4.3% during the forecast period, owing to increasing cases of breast cancer, which is expected to drive the market growth over the forecast period. For instance, according to the data provided by the National Center for Biotechnology Information, in September 2021, it is estimated that around 2.3 million new cases of breast cancer are diagnosed every year across the globe.
- Among product type, electric segment is expected to account for largest market share during the forecast period, owing to technological advancements in product design
- Major players operating in the global mammography biopsy chair market include Wolverson X-Ray Limited, Univest-X, AKRUS GmbH & Co. KG, Z&Z Medical, Inc., GF Health Products, Inc., VELA Medical, Cone Instruments, LLC, Graham-Field Inc., Medical Positioning, Inc., Medline Industries, Inc., Champion Manufacturing Inc., and GE Healthcare
